Luc Cabel Elika Loir Gwenaelle Gravis Pernelle Lavaud Christophe Massard Laurence Albiges Giulia Baciarello Yohann Loriot Karim Fizazi
10.1186/s40425-017-0232-7
J Immunother Cancer
2017 Apr 18;5:31.
immunotherapy ipilimumab metastatic castrate-resistant prostate cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/28428880/
Antineoplastic Agents, Immunological / therapeutic use Immunotherapy / methods Ipilimumab / therapeutic use Prostatic Neoplasms, Castration-Resistant / drug therapy
Antineoplastic Agents, Immunological / therapeutic use Immunotherapy / methods Ipilimumab / therapeutic use Prostatic Neoplasms, Castration-Resistant / drug therapy Case Reports Antineoplastic Agents, Immunological / administration & dosage Antineoplastic Agents, Immunological / pharmacology Humans Ipilimumab / administration & dosage Ipilimumab / pharmacology Male Middle Aged Neoplasm Metastasis Antineoplastic Agents, Immunological Ipilimumab
PMC5394619
28428880
Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
2017